<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Viurcos-Sanabria R</submitter><funding>Consejo Nacional de Ciencia y Tecnología</funding><pubmed_abstract>The contribution of the cellular immune response to the severity of coronavirus disease 2019 (COVID-19) is still uncertain because most evidence comes from patients receiving multiple drugs able to change immune function. Herein, we conducted a prospective cohort study and obtained blood samples from 128 unvaccinated healthy volunteers to examine the &lt;i>in vitro&lt;/i> response pattern of CD4+ and CD8+ T cells and monocyte subsets to polyclonal stimuli, including anti-CD3, anti-CD28, poly I:C, severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) recombinant spike S1 protein, and lipopolysaccharide. Then, we started a six-month follow-up and registered 12 participants who got SARS-CoV-2 infection, from whom we retrospectively analyzed the basal immune response pattern of T cells a</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>897995</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9289744</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&lt;i>In Vitro&lt;/i> Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19.</pubmed_title><pmcid>PMC9289744</pmcid><pubmed_authors>Viurcos-Sanabria R</pubmed_authors><pubmed_authors>Viurcos-Sanabria V</pubmed_authors><pubmed_authors>Rizo-Tellez SA</pubmed_authors><pubmed_authors>Escobedo G</pubmed_authors><pubmed_authors>Rodriguez-Cortes O</pubmed_authors><pubmed_authors>Manjarrez-Reyna AN</pubmed_authors><pubmed_authors>Flores-Mejia R</pubmed_authors><pubmed_authors>Arroyo-Valerio A</pubmed_authors><pubmed_authors>Gonzalez-Chavez A</pubmed_authors><pubmed_authors>Mendez-Garcia LA</pubmed_authors><pubmed_authors>Leon-Pedroza JI</pubmed_authors><pubmed_authors>Solleiro-Villavicencio H</pubmed_authors><pubmed_authors>Carrillo-Ruiz JD</pubmed_authors><pubmed_authors>Gonzalez-Sanabria J</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>In Vitro&lt;/i> Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19.</name><description>The contribution of the cellular immune response to the severity of coronavirus disease 2019 (COVID-19) is still uncertain because most evidence comes from patients receiving multiple drugs able to change immune function. Herein, we conducted a prospective cohort study and obtained blood samples from 128 unvaccinated healthy volunteers to examine the &lt;i>in vitro&lt;/i> response pattern of CD4+ and CD8+ T cells and monocyte subsets to polyclonal stimuli, including anti-CD3, anti-CD28, poly I:C, severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) recombinant spike S1 protein, and lipopolysaccharide. Then, we started a six-month follow-up and registered 12 participants who got SARS-CoV-2 infection, from whom we retrospectively analyzed the basal immune response pattern of T cells a</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-08-30T03:13:30.151Z</modification><creation>2022-08-09T06:00:32.526Z</creation></dates><accession>S-EPMC9289744</accession><cross_references><pubmed>35860236</pubmed><doi>10.3389/fimmu.2022.897995</doi></cross_references></HashMap>